| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |